Gillies, R., Middleton, M., Maynard, N., Bradley, K., & Gleeson, F. (2011). Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Chicago-Zitierstil (17. Ausg.)Gillies, R., MR Middleton, N. Maynard, K. Bradley, und F. Gleeson. Additional Benefit of ¹⁸F-fluorodeoxyglucose Integrated Positron Emission Tomography/computed Tomography in the Staging of Oesophageal Cancer. 2011.
MLA-Zitierstil (9. Ausg.)Gillies, R., et al. Additional Benefit of ¹⁸F-fluorodeoxyglucose Integrated Positron Emission Tomography/computed Tomography in the Staging of Oesophageal Cancer. 2011.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.